Viewing Study NCT03307759


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2025-12-25 @ 7:09 PM
Study NCT ID: NCT03307759
Status: TERMINATED
Last Update Posted: 2025-09-15
First Post: 2017-10-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-12-07
Start Date Type: ACTUAL
Primary Completion Date: 2022-01-31
Primary Completion Date Type: ACTUAL
Completion Date: 2022-01-31
Completion Date Type: ACTUAL
First Submit Date: 2017-10-06
First Submit QC Date: None
Study First Post Date: 2017-10-12
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-01-04
Results First Submit QC Date: None
Results First Post Date: 2025-09-15
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-26
Last Update Post Date: 2025-09-15
Last Update Post Date Type: ESTIMATED